Effective August 3, 2015, James Alexander, MD, notified Cellceutix Corporation that he would resign from his position as Chief Operating Officer of the company, effective immediately. The company and Dr. Alexander agree that Dr. Alexander will transition to a part-time consultancy with the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | 0.00% | 0.00% | -69.39% |
02-01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-69.39% | 794K | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.82% | 21.97B | |
-4.92% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- IPIX Stock
- News Innovation Pharmaceuticals Inc.
- James Alexander to Resign as Chief Operating Officer of Cellceutix Corporation